Biotech

All Articles

Galapagos' stockpile as fund shows intent to form its progression

.Galapagos is actually happening under added stress from real estate investors. Having built a 9.9% ...

Cell- focused Sana gathers very first CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable management hirings, firings as w...

Allist pays Jacobio $21M, landing role in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has acquired on its own a starring role in China's KRAS market, pay...

ReNeuron leaving behind AIM swap after missing out on fundraising target

.ReNeuron has joined the lengthy checklist of biotechs to leave Greater london's AIM stock market. T...

MBX declare IPO to take opposition to Ascendis in to stage 3

.MBX Biosciences has included in the recent flurry of IPO filings. The biotech, which submitted its ...

FDA expands probe right into Lykos' MDMA tests: WSJ

.For Lykos Therapies and also the firm's prospective MDMA-assisted treatment for trauma (PTSD), the ...

Gene editor Volume giving up 131 workers

.Merely days after gene publisher Tome Biosciences announced undisclosed functional cuts, a more cle...

Repare lays off 25% of personnel as biotech standstills preclinical R&ampD

.Repare Rehab is laying off an one-fourth of its own workforce as the oncology biotech scales back i...

J &amp J apply for FDA approval of $6.5 B autoimmune medicine

.Johnson &amp Johnson has gotten one more step toward noticing a yield on its own $6.5 billion nipoc...

Gain's stage 1 succeed leads way to confirm Parkinson's medication's worth

.Increase Rehabs has actually prepared its own direct proving the performance of its own Parkinson's...